Parlodel Alternatives Compared
| Parlodel (bromocriptine) | Cabergoline | Bromocriptine |
|
|---|
| Parlodel (bromocriptine) | Cabergoline | Bromocriptine |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hyperprolactinemia, Parkinson's Disease, Acromegaly. Parlodel may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperprolactinemia. Cabergoline may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hyperprolactinemia, Parkinson's Disease, Type 2 Diabetes, Acromegaly, Tardive Dyskinesia. Bromocriptine may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Parlodel (bromocriptine) | More about Cabergoline | More about Bromocriptine | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Parlodel has an average rating of 5.8 out of 10 from a total of 16 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 44% reported a negative effect. |
Cabergoline has an average rating of 7.5 out of 10 from a total of 116 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 10% reported a negative effect. |
Bromocriptine has an average rating of 5.9 out of 10 from a total of 41 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Parlodel side effects |
View all Cabergoline side effects |
View all Bromocriptine side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cabergoline prices |
View all Bromocriptine prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other bromocriptine brands include: Cycloset |
N/A |
Cycloset, Parlodel | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
8 hours |
100 hours |
8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 459 drugs are known to interact with Parlodel:
|
A total of 156 drugs are known to interact with Cabergoline:
|
A total of 459 drugs are known to interact with Bromocriptine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
June 28, 1978 |
December 23, 1996 |
June 28, 1978 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.